找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunomodulators and Biologics in Dermatologic Treatment; Turning Theory into Neal Bhatia Book 2024 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: Helmet
21#
發(fā)表于 2025-3-25 05:56:40 | 只看該作者
22#
發(fā)表于 2025-3-25 11:12:07 | 只看該作者
JAK Inhibitors as Immunomodulators, transcription of other effector cytokines. The clinical relevance to dermatologists including the impact on inflammation and pathogenesis of diseases such as atopic dermatitis, psoriasis, vitiligo, and other conditions including clinical trial data, topical and systemic therapies, and future medica
23#
發(fā)表于 2025-3-25 12:26:16 | 只看該作者
24#
發(fā)表于 2025-3-25 18:59:28 | 只看該作者
25#
發(fā)表于 2025-3-25 20:26:20 | 只看該作者
Antibiotics and Antimicrobials as Immunomodulators,kill pathogens or to inhibit their reproduction or growth. However, many of these agents have additional immunomodulatory effects, direct and indirect, due to common pathways and structural similarities between pathogens and humans. Dermatologists are amongst the top prescribers of antimicrobial age
26#
發(fā)表于 2025-3-26 01:55:25 | 只看該作者
Integrative Therapies as Immunomodulators,rings together many facets of immunology and immunomodulation. The diverse origins of therapies, including herbal, botanical, spice roots, and other natural sources, give rise to many applications as anti-inflammatory agents. Dermatologists incorporate integrative therapies in diseases such as acne,
27#
發(fā)表于 2025-3-26 04:19:03 | 只看該作者
28#
發(fā)表于 2025-3-26 10:44:11 | 只看該作者
Immunomodulators for Common Dermatologic Disorders: A Focus on Acne, Rosacea, Seborrheic Dermatitis of inflammation in disease progression. Treatment approaches for these conditions involve targeting various contributing factors, with a focus on combination therapies tailored to disease severity. Recent advancements in microencapsulated formulations and novel agents offer promising avenues for en
29#
發(fā)表于 2025-3-26 12:52:21 | 只看該作者
30#
發(fā)表于 2025-3-26 18:07:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 21:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
麟游县| 广饶县| 宁夏| 化州市| 嫩江县| 灵武市| 尚义县| 垣曲县| 保山市| 黄冈市| 康平县| 突泉县| 玉溪市| SHOW| 淳化县| 新沂市| 同心县| 朝阳县| 绥德县| 海阳市| 岳阳县| 海原县| 长岛县| 宝清县| 共和县| 邹城市| 永登县| 交口县| 渑池县| 城步| 拜泉县| 正定县| 鸡西市| 江山市| 宣汉县| 台东县| 托克托县| 建昌县| 博野县| 砀山县| 苍南县|